跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 157 条关于
“HOCM”
全部
157
临床试验
115
药物
13
机构
0
资讯
29
2年前
Aficamten Improves Exercise Tolerance in Patients with Obstructive Hypertrophic Cardiomyopathy
去年
Breckenridge Pharmaceutical Receives FDA Approval for Generic Dehydrated Alcohol Injection for Hypertrophic Obstructive Cardiomyopathy
2年前
CAMZYOS Demonstrates Sustained Benefits in Obstructive Hypertrophic Cardiomyopathy Trial
去年
Formycon's Aflibercept Biosimilar, AHZANTIVE®/Baiama®, Receives Positive CHMP Opinion for EU Approval
去年
Aficamten Shows Potential to Help oHCM Patients Avoid Septal Reduction Therapy
去年
Sonoma Pharmaceuticals Expands HOCl Technology Reach with Major US Retail and Hospital Launches
去年
Real-World Data Confirm Mavacamten's Effectiveness in Obstructive HCM Treatment
去年
SP-102 Shows Clinically Meaningful Results for Sciatica Treatment in CLEAR Trial Analysis
2年前
Aficamten Shows Long-Term Safety and Cardiac Benefits in HCM Patients
去年
Cytokinetics and Bayer Partner to Develop Aficamten for HCM in Japan
第 1 页,共 3 页
上一页
下一页